Whitebox Advisors’s Aspire Biopharma Warrant ASBPW Stock Holding History

Whitebox Advisors’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.97K	Hold	118,750	–	–	﹤0.01%	559
2025 Q4	$1.96K	Hold	118,750	–	–	﹤0.01%	485
2025 Q3	$3.55K	Hold	118,750	–	–	﹤0.01%	413
2025 Q2	$5.31K	Hold	118,750	–	–	﹤0.01%	357
2025 Q1	$8.04K	Hold	118,750	–	–	﹤0.01%	268
2024 Q4	$5.64K	Sell	118,750 -6,250	-5%	-$169	﹤0.01%	232
2024 Q3	$5.29K	Hold	125,000	–	–	﹤0.01%	225
2024 Q2	$5.61K	Hold	125,000	–	–	﹤0.01%	243
2024 Q1	$3.76K	Hold	125,000	–	–	﹤0.01%	258
2023 Q4	$7.5K	Hold	125,000	–	–	﹤0.01%	186
2023 Q3	$6.34K	Hold	125,000	–	–	﹤0.01%	235
2023 Q2	$6.26K	Hold	125,000	–	–	﹤0.01%	271
2023 Q1	$5.22K	Hold	125,000	–	–	﹤0.01%	414
2022 Q4	$9.99K	Hold	125,000	–	–	﹤0.01%	500
2022 Q3	$14K	Hold	125,000	–	–	﹤0.01%	610
2022 Q2	$21K	Buy	+125,000	New	+$27.2K	﹤0.01%	579

Other funds holding ASBPW

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Whitebox Advisors's ASBPW Position: Q1 2026 in Review

Whitebox Advisors held its Aspire Biopharma Warrant (ASBPW) position steady in Q1 2026 at 118,750 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Whitebox Advisors first reported a position in ASBPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $21K in Q2 2022. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

Whitebox Advisors held 118,750 shares of Aspire Biopharma Warrant worth $1.97K as of Q1 2026.
Whitebox Advisors left its Aspire Biopharma Warrant share count unchanged in Q1 2026.
Aspire Biopharma Warrant made up ﹤0.01% of Whitebox Advisors's portfolio in Q1 2026, its #559 holding.
Whitebox Advisors first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 16 quarters since.
Whitebox Advisors's Aspire Biopharma Warrant position peaked at $21K in Q2 2022.
29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Whitebox Advisors's 13F filing for Q1 2026, filed 15 May 2026.